Back to Search
Start Over
Transgene and BioInvent's oncolytic virus BT-001 shows positive Phase Ia results in solid tumour treatment
- Source :
- M2 Pharma. May 25, 2023
- Publication Year :
- 2023
-
Abstract
- M2 PHARMA-May 25, 2023-Transgene and BioInvent's oncolytic virus BT-001 shows positive Phase Ia results in solid tumour treatment (C)2023 M2 COMMUNICATIONS Biotechnology companies Transgene (Euronext Paris:TNG) and BioInvent International AB [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.750581836